Accession Number:

AD1050371

Title:

Synthetic Lethal Metabolic Targeting of Senescent Cells after Androgen Deprivation Therapy

Descriptive Note:

Technical Report,01 Jul 2016,30 Jun 2017

Corporate Author:

University of Wisconsin System Madison United States

Personal Author(s):

Report Date:

2017-07-01

Pagination or Media Count:

27.0

Abstract:

Progression to castrate resistant prostate cancer for men with advanced prostate cancer PC results after the initiation of androgen deprivation therapy ADT. Oneunderutilized therapeutic strategy that has the potential to dramatically improve outcomes is eradicating the persistent cancer cells that remain after ADT and likely play a key role in the development of castration-resistant PC. The initiation of ADT induces susceptibilities in PC cells that make them amenable to synergistic treatment and improved cell killing.

Subject Categories:

  • Medicine and Medical Research
  • Biochemistry

Distribution Statement:

APPROVED FOR PUBLIC RELEASE